CUE BIOPHARMA INC. - COMMON STOCK
1.1250
25-November-24 11:10:24
15 minutes delayed
Stocks
+0.1050
+10.29%
Today's range
1.0500 - 1.2431
ISIN
N/A
Source
NASDAQ
-
25 Apr 2023 08:00:01 By Nasdaq GlobeNewswire
-
21 Mar 2023 16:10:00 By Nasdaq GlobeNewswire
-
Cue Biopharma to Host Business Update Call and Webcast
15 Mar 2023 08:00:00 By Nasdaq GlobeNewswire
-
Cue Biopharma to Present at Two March 2023 Investor Healthcare Conferences
01 Mar 2023 08:00:02 By Nasdaq GlobeNewswire
-
22 Feb 2023 08:00:01 By Nasdaq GlobeNewswire
-
16 Feb 2023 10:30:00 By Nasdaq GlobeNewswire
-
Cue Biopharma Announces the Appointment of Dr. Rafi Ahmed to its Scientific Advisory Board
16 Feb 2023 08:00:01 By Nasdaq GlobeNewswire
-
Cue Biopharma to Present at Two February 2023 Scientific Conferences
01 Feb 2023 08:00:01 By Nasdaq GlobeNewswire
-
Cue Biopharma Announces Chief Medical Officer Transition
23 Jan 2023 08:00:00 By Nasdaq GlobeNewswire
-
Cue Biopharma to Present at Two Upcoming Investor Healthcare Conferences
22 Nov 2022 08:00:04 By Nasdaq GlobeNewswire
-
Cue Biopharma Reports Third Quarter 2022 Financial Results
14 Nov 2022 16:01:00 By Nasdaq GlobeNewswire
-
Cue Biopharma Announces $30 Million Private Investment in Public Equity (PIPE) Financing
14 Nov 2022 08:20:14 By Nasdaq GlobeNewswire
-
Cue Biopharma to Present at Two Upcoming Investor Healthcare Conferences in November
09 Nov 2022 08:00:03 By Nasdaq GlobeNewswire
-
Cue Biopharma to Host Business Update Call and Webcast
07 Nov 2022 08:00:02 By Nasdaq GlobeNewswire
-
05 Oct 2022 08:00:01 By Nasdaq GlobeNewswire
-
04 Oct 2022 08:00:01 By Nasdaq GlobeNewswire
-
Cue Biopharma to Present at Two September 2022 Scientific Conferences
07 Sep 2022 08:00:01 By Nasdaq GlobeNewswire
-
22 Aug 2022 08:00:01 By Nasdaq GlobeNewswire
-
Cue Biopharma Reports Second Quarter 2022 Financial Results
04 Aug 2022 16:30:00 By Nasdaq GlobeNewswire